| RS1395922945 |
DSPP
|
Health Risk |
Pathogenic/Likely pathogenic |
Deafness, autosomal dominant 39 |
| RS139593613 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS139593707 |
COL1A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS1395940101 |
RSPH9
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS139594532 |
C12orf57;RNU7-1
|
Health Risk |
Conflicting classifications of pathogenicity |
Aicardi-Goutieres syndrome 9, Aicardi-Goutieres syndrome 9 |
| RS139595011 |
GAA
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type II |
| RS139595158 |
COG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital disorder of glycosylation, type IIq |
| RS1395953286 |
HOGA1
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria type 3, Primary hyperoxaluria type 3 |
| RS139596037 |
CUBN
|
Health Risk |
Conflicting classifications of pathogenicity |
Imerslund-Grasbeck syndrome type 1, Imerslund-Grasbeck syndrome |
| RS139596061 |
ITGA6
|
Health Risk |
Conflicting classifications of pathogenicity |
Junctional epidermolysis bullosa with pyloric atresia, Junctional epidermolysis bullosa with pyloric atresia |
| RS1395962146 |
DIS3L2
|
Health Risk |
Pathogenic/Likely pathogenic |
Perlman syndrome, Perlman syndrome |
| RS1395966308 |
MAX
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary pheochromocytoma and paraganglioma, Hereditary cancer-predisposing syndrome |
| RS139596860 |
ALAS2
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked erythropoietic protoporphyria, X-linked sideroblastic anemia 1 |
| RS139597295 |
ABL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital heart defects and skeletal malformations syndrome, Congenital heart defects and skeletal malformations syndrome |
| RS139598219 |
NPHS1
|
Health Risk |
Pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1395982289 |
OTUD6B
|
Health Risk |
Likely pathogenic |
— |
| RS139598272 |
PI4KA
|
Health Risk |
Pathogenic |
Polymicrogyria, perisylvian |
| RS139598980 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Lynch syndrome |
| RS1395990892 |
ABCC8
|
Health Risk |
Pathogenic |
— |
| RS1395993186 |
SLC26A4
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 4, Pendred syndrome |
| RS139599466 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS139599587 |
POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive sclerosing poliodystrophy, Progressive external ophthalmoplegia with mitochondrial DNA deletions |
| RS139599654 |
TBX3
|
Health Risk |
Conflicting classifications of pathogenicity |
Ulnar-mammary syndrome, TBX3-related disorder |
| RS139600654 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS139600659 |
MARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2U, Severe early-onset pulmonary alveolar proteinosis due to MARS deficiency |
| RS139600847 |
FANCE
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group E, Exstrophy-epispadias complex |
| RS1396008534 |
DNM1L
|
Health Risk |
Pathogenic |
— |
| RS1396012729 |
HPS4
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 4, Hermansky-Pudlak syndrome 4 |
| RS1396036517 |
SLC6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy with myoclonic atonic seizures, Epilepsy with myoclonic atonic seizures |
| RS139603739 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS139605410 |
HSPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Schwartz-Jampel syndrome, Lethal Kniest-like syndrome |
| RS1396054344 |
POLR3A
|
Health Risk |
Pathogenic |
— |
| RS139605474 |
MYBPC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Arthrogryposis, distal |
| RS1396066255 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1DD, Cardiovascular phenotype |
| RS139606653 |
MMP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Multicentric osteolysis nodulosis arthropathy spectrum, Multicentric osteolysis nodulosis arthropathy spectrum |
| RS139606810 |
OPA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Optic atrophy 3, 3-Methylglutaconic aciduria type 3 |
| RS139606873 |
CCNO
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 29 |
| RS139607138 |
UMOD
|
Health Risk |
Conflicting classifications of pathogenicity |
UMOD-related disorder, UMOD-related disorder |
| RS139607465 |
MCPH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 1, primary |
| RS139607673 |
UGT1A1
|
Health Risk |
Pathogenic |
Crigler-Najjar syndrome, Crigler-Najjar syndrome |
| RS139607688 |
TREM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2, Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2 |
| RS139608070 |
CACNA2D1
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome, Cardiovascular phenotype |
| RS1396081975 |
LMX1A
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 7, Autosomal dominant nonsyndromic hearing loss 7 |
| RS1396093690 |
TERT
|
Health Risk |
Conflicting classifications of pathogenicity |
Dyskeratosis congenita, autosomal dominant 2 |
| RS139610204 |
NEBL
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary dilated cardiomyopathy, Primary dilated cardiomyopathy |
| RS1396104394 |
WT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilms tumor 1, 11p partial monosomy syndrome |
| RS139610577 |
BLM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Bloom syndrome |
| RS139610730 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, type 4 |
| RS139611589 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS1396120018 |
SLC26A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Achondrogenesis, type IB |
| RS1396124456 |
TBX5
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic valve disease 2, Cardiovascular phenotype |
| RS1396150639 |
NAGLU
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS1396150679 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS139616052 |
SMAD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Aneurysm-osteoarthritis syndrome |
| RS139616809 |
WNT5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant Robinow syndrome 1, Autosomal dominant Robinow syndrome 1 |
| RS1396168176 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS139616911 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS1396171148 |
FARSB
|
Health Risk |
Pathogenic |
Cirrhosis of liver, Cerebral calcification |
| RS139617644 |
TCIRG1
|
Health Risk |
Pathogenic |
Autosomal recessive osteopetrosis 1, Osteopetrosis |
| RS139617694 |
LDLR
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypercholesterolemia, familial |
| RS1396179636 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Arrhythmogenic cardiomyopathy with wooly hair and keratoderma |
| RS139618756 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS139618850 |
ANO5
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2L, Gnathodiaphyseal dysplasia |
| RS1396189205 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS139619013 |
IFT140
|
Health Risk |
Conflicting classifications of pathogenicity |
Saldino-Mainzer syndrome, IFT140-related disorder |
| RS1396196056 |
CEBPE
|
Health Risk |
Pathogenic/Likely pathogenic |
Specific granule deficiency, Specific granule deficiency |
| RS139619724 |
SLC7A7
|
Health Risk |
Conflicting classifications of pathogenicity |
Lysinuric protein intolerance, Autoinflammatory syndrome |
| RS139620052 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS139620139 |
FAM20A
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta type 1G, Amelogenesis imperfecta type 1G |
| RS139620148 |
ABCC9
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Intellectual disability and myopathy syndrome |
| RS139620380 |
FBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital contractural arachnodactyly, Ehlers-Danlos syndrome |
| RS139620474 |
MMP9
|
Health Risk |
Likely pathogenic |
Metaphyseal anadysplasia 2, Metaphyseal anadysplasia 2 |
| RS139620961 |
AIRE
|
Health Risk |
Conflicting classifications of pathogenicity |
Polyglandular autoimmune syndrome, type 1 |
| RS139621265 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypobetalipoproteinemia 1, Hypercholesterolemia |
| RS139622189 |
NHERF1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS139622306 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa dystrophica inversa, autosomal recessive |
| RS1396225514 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS139622861 |
SPTBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental delay, impaired speech |
| RS139623406 |
ANK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Spherocytosis, Hereditary spherocytosis type 1 |
| RS139624145 |
LDLR
|
Health Risk |
Likely pathogenic |
Hypercholesterolemia, familial |
| RS139624629 |
DPM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital disorder of glycosylation type 1E, Congenital disorder of glycosylation type 1E |
| RS139624657 |
PRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease |
| RS1396249069 |
SPTA1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS139625105 |
CHRNE
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome, Congenital myasthenic syndrome 4A |
| RS139626312 |
PNPLA8
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial myopathy-lactic acidosis-deafness syndrome, PNPLA8-related disorder |
| RS139626522 |
UPK3A
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal hypodysplasia/aplasia 1, Renal hypodysplasia/aplasia 1 |
| RS1396269749 |
DNAAF1
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1396273375 |
C5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS139628387 |
AUH
|
Health Risk |
Conflicting classifications of pathogenicity |
3-methylglutaconic aciduria type 1, 3-methylglutaconic aciduria type 1 |
| RS139628442 |
CLDN14
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 29, CLDN14-related disorder |
| RS1396286715 |
CHRNE
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 4C, Congenital myasthenic syndrome 4B |
| RS1396292043 |
DNAJC21
|
Health Risk |
Pathogenic |
— |
| RS139629564 |
DNAJC21
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, DNAJC21-related disorder |
| RS139629694 |
JAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alagille syndrome due to a JAG1 point mutation, JAG1-related disorder |
| RS1396302901 |
CTNNA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS139631202 |
TRAPPC9
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal recessive 13 |
| RS1396313317 |
CNTNAP2
|
Health Risk |
Likely pathogenic |
Autism spectrum disorder, Autism spectrum disorder |
| RS1396314595 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS139632595 |
EXOSC9
|
Health Risk |
Pathogenic/Likely pathogenic |
Pontocerebellar hypoplasia, type 1D |
| RS139633388 |
CP
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of ferroxidase, Hypoceruloplasminemia |